申请人:Bradley Stuart Edward
公开号:US20090221644A1
公开(公告)日:2009-09-03
Compounds of formula (I): or pharmaceutically acceptable salts thereof, are GPCR agonists and are useful as for the treatment of obesity and diabetes.
式(I)的化合物或其药学上可接受的盐,是GPCR激动剂,可用于治疗肥胖和糖尿病。